Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells

Background: Several mechanisms of action have been proposed to explain the apparent antineoplastic functions of metformin, many of which are observed at high concentrations that may not be reflective of achievable tissue concentrations. We propose that metformin at low concentrations functions to in...

Full description

Bibliographic Details
Main Authors: Chandler Schexnayder, Kiera Broussard, Demitrius Onuaguluchi, Anthony Poché, Moamen Ismail, LeFontae McAtee, Shawn Llopis, Amber Keizerweerd, Harris McFerrin, Christopher Williams
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/19/11/3692
_version_ 1811269451815845888
author Chandler Schexnayder
Kiera Broussard
Demitrius Onuaguluchi
Anthony Poché
Moamen Ismail
LeFontae McAtee
Shawn Llopis
Amber Keizerweerd
Harris McFerrin
Christopher Williams
author_facet Chandler Schexnayder
Kiera Broussard
Demitrius Onuaguluchi
Anthony Poché
Moamen Ismail
LeFontae McAtee
Shawn Llopis
Amber Keizerweerd
Harris McFerrin
Christopher Williams
author_sort Chandler Schexnayder
collection DOAJ
description Background: Several mechanisms of action have been proposed to explain the apparent antineoplastic functions of metformin, many of which are observed at high concentrations that may not be reflective of achievable tissue concentrations. We propose that metformin at low concentrations functions to inhibit ROS production and inflammatory signaling in breast cancer, thereby reducing metastasis. Methods: Using the highly invasive MDA-MB-231 breast carcinoma model, we ascertained the impact of metformin on cell viability by DNA content analysis and fluorescent dye exclusion. Migration and invasion assays were performed using a modified Boyden chamber assay and metastasis was ascertained using the chorioallantoic membrane (CAM) assay. PGE2 production was measured by Enzyme-Linked Immunosorbent Assay (ELISA). COX2 and ICAM1 levels were determined by flow cytometry immunoassay. Results: Metformin acutely decreased cell viability and caused G2 cell cycle arrest only at high concentrations (10 mM). At 100 µM, however, metformin reduced ICAM1 and COX2 expression, as well as reduced PGE2 production and endogenous mitochondrial ROS production while failing to significantly impact cell viability. Consequently, metformin inhibited migration, invasion in vitro and PGE2-dependent metastasis in CAM assays. Conclusion: At pharmacologically achievable concentrations, metformin does not drastically impact cell viability, but inhibits inflammatory signaling and metastatic progression in breast cancer cells.
first_indexed 2024-04-12T21:42:17Z
format Article
id doaj.art-a30513887b584a7786524b010873233f
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-12T21:42:17Z
publishDate 2018-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a30513887b584a7786524b010873233f2022-12-22T03:15:44ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-11-011911369210.3390/ijms19113692ijms19113692Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer CellsChandler Schexnayder0Kiera Broussard1Demitrius Onuaguluchi2Anthony Poché3Moamen Ismail4LeFontae McAtee5Shawn Llopis6Amber Keizerweerd7Harris McFerrin8Christopher Williams9College of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USACollege of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USACollege of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USACollege of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USADepartment of Biology, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USACollege of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USACollege of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USACollege of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USADepartment of Biology, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USACollege of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USABackground: Several mechanisms of action have been proposed to explain the apparent antineoplastic functions of metformin, many of which are observed at high concentrations that may not be reflective of achievable tissue concentrations. We propose that metformin at low concentrations functions to inhibit ROS production and inflammatory signaling in breast cancer, thereby reducing metastasis. Methods: Using the highly invasive MDA-MB-231 breast carcinoma model, we ascertained the impact of metformin on cell viability by DNA content analysis and fluorescent dye exclusion. Migration and invasion assays were performed using a modified Boyden chamber assay and metastasis was ascertained using the chorioallantoic membrane (CAM) assay. PGE2 production was measured by Enzyme-Linked Immunosorbent Assay (ELISA). COX2 and ICAM1 levels were determined by flow cytometry immunoassay. Results: Metformin acutely decreased cell viability and caused G2 cell cycle arrest only at high concentrations (10 mM). At 100 µM, however, metformin reduced ICAM1 and COX2 expression, as well as reduced PGE2 production and endogenous mitochondrial ROS production while failing to significantly impact cell viability. Consequently, metformin inhibited migration, invasion in vitro and PGE2-dependent metastasis in CAM assays. Conclusion: At pharmacologically achievable concentrations, metformin does not drastically impact cell viability, but inhibits inflammatory signaling and metastatic progression in breast cancer cells.https://www.mdpi.com/1422-0067/19/11/3692metforminICAM1metastasisreactive oxygen speciesCOX2
spellingShingle Chandler Schexnayder
Kiera Broussard
Demitrius Onuaguluchi
Anthony Poché
Moamen Ismail
LeFontae McAtee
Shawn Llopis
Amber Keizerweerd
Harris McFerrin
Christopher Williams
Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells
International Journal of Molecular Sciences
metformin
ICAM1
metastasis
reactive oxygen species
COX2
title Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells
title_full Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells
title_fullStr Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells
title_full_unstemmed Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells
title_short Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells
title_sort metformin inhibits migration and invasion by suppressing ros production and cox2 expression in mda mb 231 breast cancer cells
topic metformin
ICAM1
metastasis
reactive oxygen species
COX2
url https://www.mdpi.com/1422-0067/19/11/3692
work_keys_str_mv AT chandlerschexnayder metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT kierabroussard metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT demitriusonuaguluchi metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT anthonypoche metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT moamenismail metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT lefontaemcatee metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT shawnllopis metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT amberkeizerweerd metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT harrismcferrin metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells
AT christopherwilliams metformininhibitsmigrationandinvasionbysuppressingrosproductionandcox2expressioninmdamb231breastcancercells